Microglial Dysregulation in Psychiatric Disease
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Microglia, the brain's resident immune cells, are phagocytes of the macrophage lineage that have a key role in responding to inflammation and immune challenge in the brain. More recently, they have been shown to have a number of important roles beyond immune surveillance and response, including synaptic pruning during development and the support of adult neurogenesis. Microglial abnormalities have been found in several neuropsychiatric conditions, though in most cases it remains unclear whether these are causative or are a reaction to some other underlying pathophysiology. Here we summarize postmortem, animal, neuroimaging, and other evidence for microglial pathology in major depression, schizophrenia, autism, obsessive-compulsive disorder, and Tourette syndrome. We identify gaps in the existing literature and important areas for future research. If microglial pathology proves to be an important causative factor in these or other neuropsychiatric diseases, modulators of microglial function may represent a novel therapeutic strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, microglia may play roles in neurodevelopmental and psychiatric diseases such as autism, schizophrenia (Scz) and depression (16, 17).”
From An environment-dependent transcriptional network specifies human microglia identity (2017) · cites this paper as [17]
In the citing paper
“the review also found that aggregated animal studies commonly implicated microglial activation with depressive phenotypes in rats that undergo chronic psychological stress, neonatal LPS injection, and mice with CX3CR1 (fractalkine receptor) deficiencies.”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Frick et al., 2013
In the citing paper
“A review (Frick et al., 2013) detailing studies concerning cytokine effects on different immune cells indicated that data on microglial dysregulation are “limited” and reported mixed results relating to increased microglial densities and activation in diagnosed MDD patients in both clinical and post-mortem examinations.”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Frick et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 2×
“Microglia have been found to be required for the development of mature synapses during embryogenesis [1] and to regulate the number of functional synapses both in culture [2] and in vivo [3].”
BackgroundMicroglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · cited 3×
“However, dysregulation of this physiological process can lead to neurodegeneration [8, 13].”
BackgroundNeuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 1×
“An initial study found marked microglial activation, measured by immunohistochemical quantification of HLA-DR expression, in the cerebellum, several cortical regions, and white matter in patients with autism [85].”
BackgroundStress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
Self-citationSynaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · cited 2×
“[5] R.”
BackgroundMicroglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622 · cited 1×
“They also regulate adult neurogenesis [4].”
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
The Role of Microglia in the Healthy Brain: Figure 1.
Tremblay, M.-È., Stevens, B., Sierra, A., Wake, H., Bessis, A., & Nimmerjahn, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4158-11.2011 · Cited by 992 · cited 2×
“Microglia are highly motile cells, extruding and retracting their processes every few minutes [9].”
BackgroundSteiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H.-G., & Bogerts, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.013 · Cited by 791 · cited 2×
“However, significant microgliosis has been observed in patients with depression who completed suicide, compared to patients who died via other methods and healthy controls [29].”
BackgroundResultCytokine, Sickness Behavior, and Depression
Dantzer, R. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.002 · Cited by 789 · cited 1×
“Certain core symptoms of major depression, especially the somatic symptoms, resemble the “sickness behavior” that is produced by systemic infectious or inflammatory conditions [26].”
BackgroundMorgan, J. T., Chana, G., Pardo, C. A., Achim, C., Semendeferi, K., Buckwalter, J., Courchesne, E., & Everall, I. P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.024 · Cited by 749 · cited 1×
“A subsequent study described both increased density of microglial cells in the dorsolateral prefrontal cortex and a shift towards an amoeboid morphology, characterized by soma enlargement, process retraction and thickening, and extension of filopodia from processes, that is suggestive of activation and differentiation…”
BackgroundEarly-life programming of later-life brain and behavior: a critical role for the immune system
Bilbo, S. D. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.014.2009 · Cited by 652
Wohleb, E. S., Hanke, M. L., Corona, A. W., Powell, N. D., Stiner, L. M., Bailey, M. T., Nelson, R. J., Godbout, J. P., & Sheridan, J. F. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0450-11.2011 · Cited by 638
Dynamics of microglial activation: A confocal time-lapse analysis in hippocampal slices
Stence, N., Waite, M., & Dailey, M. E. (2001) · Glia · doi:10.1002/1098-1136(200103)33:3<256::aid-glia1024>3.0.co;2-j · Cited by 625
CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity
Rogers, J. T., Morganti, J. M., Bachstetter, A. D., Hudson, C. E., Peters, M. M., Grimmig, B. A., Weeber, E. J., Bickford, P. C., & Gemma, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3667-11.2011 · Cited by 624 · cited 1×
“Mice that lack the CX3CR1 have impaired cognitive function and synaptic plasticity [24].”
BackgroundFillman, S. G., Cloonan, N., Catts, V. S., Miller, L. C., Wong, J., McCrossin, T., Cairns, M., & Weickert, C. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.110 · Cited by 609 · cited 1×
“In another recent study, the density of cells positive for the β subunit of the MHC-II, which is common to HLA-DP/DR/DQ and is expressed on activated microglia, correlated with IL-1β expression in the brains of schizophrenic patients [60].”
BackgroundWild-type microglia arrest pathology in a mouse model of Rett syndrome
Derecki, N. C., Cronk, J. C., Lu, Z., Xu, E., Abbott, S. B. G., Guyenet, P. G., & Kipnis, J. (2012) · Nature · doi:10.1038/nature10907 · Cited by 607 · cited 2×
“In this regard, the recent demonstration that bone marrow transplant (and thus microglial replacement) can mitigate core phenotypes in a Rett model mouse is of immense importance [100].”
BackgroundSaederup, N., Cardona, A. E., Croft, K., Mizutani, M., Cotleur, A. C., Tsou, C.-L., Ransohoff, R. M., & Charo, I. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013693 · Cited by 599
Quinolinic acid, the inescapable neurotoxin
Guillemin, G. J. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08485.x · Cited by 595 · cited 1×
“At sufficient doses, quinolinic acid (QA) is a neurotoxin, a gliotoxin, a proinflammatory mediator, and an oxidant and can alter the integrity and cohesion of the blood-brain barrier [35].”
Backgroundvan Berckel, B. N., Bossong, M. G., Boellaard, R., Kloet, R., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A. D., Cahn, W., Lammertsma, A. A., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.025 · Cited by 582
Steiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Doorduin, J., de Vries, E. F. J., Willemsen, A. T. M., de Groot, J. C., Dierckx, R. A., & Klein, H. C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066647 · Cited by 559 · cited 1×
“Binding of one such agent, (R)-[(11)C]PK11195, was increased, suggesting differential microglial activation, in gray matter [65] and in hippocampus [66] of patients with schizophrenia.”
BackgroundMicroglial Activation in Young Adults With Autism Spectrum Disorder
Suzuki, K., Sugihara, G., Ouchi, Y., Nakamura, K., Futatsubashi, M., Takebayashi, K., Yoshihara, Y., Omata, K., Matsumoto, K., Tsuchiya, K. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.272 · Cited by 523 · cited 1×
“Increased [(11)C]PK11195 binding was observed in multiple brain regions (cerebellum, midbrain, pons, fusiform gyri, and the anterior cingulate and orbitofrontal cortices) in young adult subjects with autism spectrumdisorder, suggesting increasedmicroglial activation [89].”
BackgroundHagberg, H., Gressens, P., & Mallard, C. (2012) · Annals of Neurology · doi:10.1002/ana.22620 · Cited by 514 · cited 1×
“For example, maternal infection during pregnancy has been associated with schizophrenia, at least at the epidemiological level (reviewed in [54, 55]).”
BackgroundMACFABE, D., CAIN, D., RODRIGUEZCAPOTE, K., FRANKLIN, A., HOFFMAN, J., BOON, F., TAYLOR, A., KAVALIERS, M., & OSSENKOPP, K. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.025 · Cited by 497 · cited 1×
“Propionic acid-induced autistic-like behavior in laboratory animals is also accompanied by microglial activation, assayed as increased CD68 expression [93, 94].”
BackgroundHematopoietic origin of pathological grooming in Hoxb8 mutant mice
Chen, S.-K., Tvrdik, P., Peden, E., Cho, S., Wu, S., Spangrude, G., & Capecchi, M. R. (2010) · Cell · doi:10.1016/j.cell.2010.03.055 · Cited by 450
Hinwood, M., Morandini, J., Day, T. A., & Walker, F. R. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr229 · Cited by 420 · cited 1×
“Chronic psychological stress, which can contribute to the development of depression [37], increases microglia activation in the prefrontal cortex of rats; the antibiotic minocycline, an anti-inflammatory drug that blocks microglial activation, is able to reverse both microglial abnormalities and attendant cognitive dy…”
BackgroundNeuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease
Reynolds, A. D., Banerjee, R., Liu, J., Gendelman, H. E., & Lee Mosley, R. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507296 · Cited by 420 · cited 2×
“[14] A.”
BackgroundQuantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8
Wang, G. G., Calvo, K. R., Pasillas, M. P., Sykes, D. B., Häcker, H., & Kamps, M. P. (2006) · Nature Methods · doi:10.1038/nmeth865 · Cited by 407 · cited 1×
“[108] G.”
Hoxb8 Is Required for Normal Grooming Behavior in Mice
Greer, J. M., & Capecchi, M. R. (2002) · Neuron · doi:10.1016/s0896-6273(01)00564-5 · Cited by 401 · cited 1×
“Ten years ago, mice with a knockout of the HoxB8 gene, a homeobox developmental patterning gene expressed prominently in macrophage-lineage hematopoietic cells, were observed to exhibit excessive grooming behavior; this excessive grooming has been proposed to model OCD symptomatology [103] More recently, HoxB8 mutant…”
BackgroundLevkovitz, Y., Mendlovich, S., Riwkes, S., Braw, Y., Levkovitch-Verbin, H., Gal, G., Fennig, S., Treves, I., & Kron, S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04666yel · Cited by 387 · cited 2×
“The apparent ability of minocycline augmentation to improve the symptoms of schizophrenia [83, 84] provides some early clinical evidence for a causal role for microglial activation in this condition, though this conclusion is limited by minocycline’s multiple mechanisms of action.”
BackgroundResultTynan, R. J., Weidenhofer, J., Hinwood, M., Cairns, M. J., Day, T. A., & Walker, F. R. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.12.011 · Cited by 386
Emerging role of glutamate in the pathophysiology of major depressive disorder
Hashimoto, K. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.005 · Cited by 381
Butovsky, O., Talpalar, A. E., Ben-Yaakov, K., & Schwartz, M. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.03.005 · Cited by 365 · cited 3×
“These results suggest that CX3CR1/CX3CL1 negatively regulates depressogenic actions of activated microglia [44], perhaps by directing microglia towards a neuroprotective phenotype [18, 19].”
BackgroundMacFabe, D. F., Cain, N. E., Boon, F., Ossenkopp, K.-P., & Cain, D. P. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.10.005 · Cited by 365 · cited 1×
“Propionic acid-induced autistic-like behavior in laboratory animals is also accompanied by microglial activation, assayed as increased CD68 expression [93, 94].”
BackgroundFractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats
Bachstetter, A. D., Morganti, J. M., Jernberg, J., Schlunk, A., Mitchell, S. H., Brewster, K. W., Hudson, C. E., Cole, M. J., Harrison, J. K., Bickford, P. C., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.022 · Cited by 364 · cited 1×
“CX3CR1+microglial cells are also required to support hippocampal neurogenesis [25].”
BackgroundRett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate
Maezawa, I., & Jin, L.-W. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5966-09.2010 · Cited by 347 · cited 1×
“MECP2-deficientmicroglia release excess glutamate, in vitro, via connexin 32 (Cx32) hemichannel-mediated release, as a consequence of enhanced glutaminase expression [95].”
BackgroundMizutani, M., Pino, P. A., Saederup, N., Charo, I. F., Ransohoff, R. M., & Cardona, A. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100421 · Cited by 346
Increase in HLA-DR Immunoreactive Microglia in Frontal and Temporal Cortex of Chronic Schizophrenics
Radewicz, K., Garey, L. J., Gentleman, S. M., & Reynolds, R. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.2.137 · Cited by 342 · cited 2×
“Several other postmortem studies have provided further evidence of microglial activation, and of brain infiltration by other immune cells, in schizophrenia [29, 61–64].”
BackgroundMaes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325 · cited 1×
“All of these effects—inflammation, oxidative stress, impaired neurogenesis, reduced glial cell number, and neuronal damage—have been implicated in depression [36].”
BackgroundEvidence for activation of microglia in patients with psychiatric illnesses
Bayer, T. A., Buslei, R., Havas, L., & Falkai, P. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00545-5 · Cited by 323 · cited 3×
“A small early postmortem study found aberrant activation of microglial cells characterized by HLA-DR expression in a subset of individuals with schizophrenia [28], though other small early studies did not replicate this finding [56].”
BackgroundResultCzeh, M., Gressens, P., & Kaindl, A. M. (2011) · Developmental Neuroscience · doi:10.1159/000328989 · Cited by 321 · cited 1×
“However, dysregulation of this physiological process can lead to neurodegeneration [8, 13].”
BackgroundNeuroplastic changes in depression: A role for the immune system
Eyre, H., & Baune, B. T. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.019 · Cited by 319 · cited 2×
“Many studies have shown abnormalities in peripheral cytokines in depressed patients; indeed, these data have led some investigators to propose a primary immunological etiology for major depressive disorder [7].”
BackgroundInterferon-Induced Depression in Chronic Hepatitis C: A Systematic Review and Meta-Analysis
Udina, M., Castellví, P., Moreno-España, J., Navinés, R., Valdés, M., Forns, X., Langohr, K., Solà, R., Vieta, E., & Martín-Santos, R. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07694 · Cited by 297
Microglia in the Cerebral Cortex in Autism
Tetreault, N. A., Hakeem, A. Y., Jiang, S., Williams, B. A., Allman, E., Wold, B. J., & Allman, J. M. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1513-0 · Cited by 288 · cited 1×
“Similar results have been reported in the frontoinsular and visual cortices [87].”
ResultMicroglia Actively Regulate the Number of Functional Synapses
Ji, K., Akgul, G., Wollmuth, L. P., & Tsirka, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056293 · Cited by 280 · cited 1×
“Microglia have been found to be required for the development of mature synapses during embryogenesis [1] and to regulate the number of functional synapses both in culture [2] and in vivo [3].”
BackgroundChaudhry, I. B., Hallak, J., Husain, N., Minhas, F., Stirling, J., Richardson, P., Dursun, S., Dunn, G., & Deakin, B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444941 · Cited by 279 · cited 2×
“The apparent ability of minocycline augmentation to improve the symptoms of schizophrenia [83, 84] provides some early clinical evidence for a causal role for microglial activation in this condition, though this conclusion is limited by minocycline’s multiple mechanisms of action.”
BackgroundResultWohleb, E. S., Fenn, A. M., Pacenta, A. M., Powell, N. D., Sheridan, J. F., & Godbout, J. P. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.02.003 · Cited by 275
Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization
Steiner, J., Mawrin, C., Ziegeler, A., Bielau, H., Ullrich, O., Bernstein, H.-G., & Bogerts, B. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0090-8 · Cited by 229
Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells
Liu, D., Wang, Z., Liu, S., Wang, F., Zhao, S., & Hao, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.033 · Cited by 221
Mathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs · doi:10.2165/11633130-000000000-00000 · Cited by 220
Abnormal microglial–neuronal spatial organization in the dorsolateral prefrontal cortex in autism
Morgan, J. T., Chana, G., Abramson, I., Semendeferi, K., Courchesne, E., & Everall, I. P. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.036 · Cited by 214 · cited 1×
“Interestingly, the organization of microglianeuron interactions may be abnormal in autism; microglia are distributed closer to neurons of the dorsolateral prefrontal cortex [88].”
BackgroundMiyaoka, T., Wake, R., Furuya, M., Liaury, K., Ieda, M., Kawakami, K., Tsuchie, K., Taki, M., Ishihara, K., Araki, T., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.002 · Cited by 212 · cited 1×
“In openlabel studies, Miyaoka and colleagues found a significant decrease in both positive and negative symptoms after minocycline was added to an antipsychotic in subjects with schizophrenia [81], andwhen it was added to an antipsychotic and antidepressant in individuals with psychotic depression [82].”
BackgroundPPAR ? agonists stimulate oligodendrocyte differentiation in tissue culture
Saluja, I., Granneman, J. G., & Skoff, R. P. (2001) · Glia · doi:10.1002/1098-1136(200103)33:3<191::aid-glia1018>3.0.co;2-m · Cited by 200
Corona, A. W., Huang, Y., O'Connor, J. C., Dantzer, R., Kelley, K. W., Popovich, P. G., & Godbout, J. P. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-93 · Cited by 200 · cited 4×
“These results suggest that CX3CR1/CX3CL1 negatively regulates depressogenic actions of activated microglia [44], perhaps by directing microglia towards a neuroprotective phenotype [18, 19].”
BackgroundInfluentialAntidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide
Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., & Kanba, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.022 · Cited by 198
CCL2/MCP-1 modulation of microglial activation and proliferation
Hinojosa, A. E., Garcia-Bueno, B., Leza, J. C., & Madrigal, J. L. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-77 · Cited by 197 · cited 1×
“CCL2/MCP-1 triggers microglia proliferation and also serves as a signal for microglia-induced neurodegeneration [21, 22].”
BackgroundBusse, S., Busse, M., Schiltz, K., Bielau, H., Gos, T., Brisch, R., Mawrin, C., Schmitt, A., Jordan, W., Müller, U. J., et al. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.08.005 · Cited by 194 · cited 2×
“The distinction between patterns of immune dysregulation in paranoid versus residual schizophrenia described above [63] provides one candidate hypothesis to explain this heterogeneity.”
BackgroundGlutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications
Coyle, J. T., Basu, A., Benneyworth, M., Balu, D., & Konopaske, G. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-25758-2_10 · Cited by 180 · cited 1×
“In particular, dysregulated synaptic physiology has been a major focus of recent interest in studies of the pathophysiology of mood [5] and psychotic disorders [6], and abnormalities of neurogenesis may similarly contribute to psychiatric disease [7].”
BackgroundRisperidone significantly inhibits interferon-γ-induced microglial activation in vitro
Kato, T., Monji, A., Hashioka, S., & Kanba, S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.019 · Cited by 174
Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder
Bhattacharyya, S., Khanna, S., Chakrabarty, K., Mahadevan, A., Christopher, R., & Shankar, S. K. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.77 · Cited by 172 · cited 2×
“, [101, 102]).”
Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS
Prinz, M., & Priller, J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.015 · Cited by 172 · cited 1×
“Fractalkine (CX3CL1) and its receptor (CX3CR1) are also involved in immune cell trafficking to the central nervous system [23].”
BackgroundDrexhage, R. C., Hoogenboezem, T. A., Cohen, D., Versnel, M. A., Nolen, W. A., van Beveren, N. J. M., & Drexhage, H. A. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001653 · Cited by 169 · cited 2×
“Several other postmortem studies have provided further evidence of microglial activation, and of brain infiltration by other immune cells, in schizophrenia [29, 61–64].”
BackgroundAberrant immune responses in a mouse with behavioral disorders
Heo, Y., Zhang, Y., Gao, D., Miller, V. M., & Lawrence, D. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020912 · Cited by 168 · cited 1×
“For instance, BTBR T+tf /J mice, which exhibit reduced social interaction and a restricted behavioral repertoire, recapitulating some of the core symptoms of autism, have increased MHC2-expressing microglia compared to control mice [90].”
BackgroundMicroglial activation in a neuroinflammational animal model of schizophrenia – a pilot study
Juckel, G., Manitz, M. P., Brüne, M., Friebe, A., Heneka, M. T., & Wolf, R. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.018 · Cited by 165 · cited 1×
“An increased number of microglial cells and reduced arborization, which suggests activation, were also found in the hippocampus and the striatum of young rodents following embryonic polyriboinosinicpolyribocytidylic acid (Poly I:C) exposure [68, 69], which is proposed to recapitulate disrupted brain-immune interaction…”
BackgroundTGFβ signalling plays an important role in IL4-induced alternative activation of microglia
Zhou, X., Spittau, B., & Krieglstein, K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-210 · Cited by 159 · cited 1×
“As noted above, microglia are of the hematopoetic lineage, though they populate the brain early in development.”
BackgroundBian, Q., Kato, T. A., Monji, A., Hashioka, S., Mizoguchi, Y., Horikawa, H., & Kanba, S. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.06.031 · Cited by 156
Corona, A. W., Norden, D. M., Skendelas, J. P., Huang, Y., O’Connor, J. C., Lawson, M., Dantzer, R., Kelley, K. W., & Godbout, J. P. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.08.008 · Cited by 152 · cited 2×
“[45] A.”
BackgroundAnderson, G., & Maes, M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.014 · Cited by 146 · cited 1×
“For example, maternal infection during pregnancy has been associated with schizophrenia, at least at the epidemiological level (reviewed in [54, 55]).”
BackgroundMinocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
Miyaoka, T., Yasukawa, R., Yasuda, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181593d45 · Cited by 146 · cited 1×
“In openlabel studies, Miyaoka and colleagues found a significant decrease in both positive and negative symptoms after minocycline was added to an antipsychotic in subjects with schizophrenia [81], andwhen it was added to an antipsychotic and antidepressant in individuals with psychotic depression [82].”
BackgroundImmune-Glutamatergic Dysfunction as a Central Mechanism of the Autism Spectrum Disorders
Blaylock, R., & Strunecka, A. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787002745 · Cited by 138 · cited 1×
“Immune-mediated dysregulation of glutamatergic neurotransmission has been proposed as a pathogenic mechanism in autism spectrum disorders more generally [99].”
BackgroundWierzba‐Bobrowicz, T., Lewandowska, E., Lechowicz, W., Stępień, T., & Pasennik, E. (2005) · PubMed · Cited by 136
Expression of CD40 in the brain of Alzheimer’s disease and other neurological diseases
Togo, T., Akiyama, H., Kondo, H., Ikeda, K., Kato, M., Iseki, E., & Kosaka, K. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02984-x · Cited by 131 · cited 1×
“A small early postmortem study found aberrant activation of microglial cells characterized by HLA-DR expression in a subset of individuals with schizophrenia [28], though other small early studies did not replicate this finding [56].”
ResultHorikawa, H., Kato, T. A., Mizoguchi, Y., Monji, A., Seki, Y., Ohkuri, T., Gotoh, L., Yonaha, M., Ueda, T., Hashioka, S., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.015 · Cited by 131
Altered Development of Glutamate and GABA Receptors in the Basal Ganglia of Girls with Rett Syndrome
Blue, M. E., Naidu, S., & Johnston, M. V. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7030 · Cited by 126 · cited 1×
“Reductions in AMPA and NMDA glutamate receptor density in the putamen and in kainate (KA) glutamate receptor density in the caudate of Rett patients have also reported [97].”
BackgroundUltrastructural damage of capillaries in the neocortex in schizophrenia
Uranova, N. A., Zimina, I. S., Vikhreva, O. V., Krukov, N. O., Rachmanova, V. I., & Orlovskaya, D. D. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903414188 · Cited by 124
Fluoxetine protects neurons against microglial activation-mediated neurotoxicity
Zhang, F., Zhou, H., Wilson, B. C., Shi, J.-S., Hong, J.-S., & Gao, H.-M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70066-9 · Cited by 123 · cited 2×
“Several antidepressants have been found to prevent the neurodegenerative activation of microglia induced by LPS and cytokines in vitro [46–52].”
BackgroundYang, G., Meng, Y., Li, W., Yong, Y., Fan, Z., Ding, H., Wei, Y., Luo, J., & Ke, Z. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00445.x · Cited by 122 · cited 1×
“CCL2/MCP-1 triggers microglia proliferation and also serves as a signal for microglia-induced neurodegeneration [21, 22].”
BackgroundKato, T., Mizoguchi, Y., Monji, A., Horikawa, H., Suzuki, S. O., Seki, Y., Iwaki, T., Hashioka, S., & Kanba, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05435.x · Cited by 122
Obuchowicz, E., Kowalski, J., Labuzek, K., Krysiak, R., Pendzich, J., & Herman, Z. S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500547x · Cited by 115
Possible antipsychotic effects of minocycline in patients with schizophrenia
Miyaoka, T., Yasukawa, R., YASUDA, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.08.013 · Cited by 111 · cited 1×
“A few years ago, uncontrolled case series began to appear reporting therapeutic benefit from the addition of minocycline to antipsychotic treatment in schizophrenia [78, 79].”
BackgroundDean, B., Gibbons, A. S., Tawadros, N., Brooks, L., Everall, I., & Scarr, E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.95 · Cited by 110
Seshadri, S., Kamiya, A., Yokota, Y., Prikulis, I., Kano, S.-I., Hayashi-Takagi, A., Stanco, A., Eom, T.-Y., Rao, S., Ishizuka, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909284107 · Cited by 108
Inhibitory Effects of Ketamine on Lipopolysaccharide-Induced Microglial Activation
Chang, Y., Lee, J.-J., Hsieh, C.-Y., Hsiao, G., Chou, D.-S., & Sheu, J.-R. (2009) · Mediators of Inflammation · doi:10.1155/2009/705379 · Cited by 108
Arakawa, S., Shirayama, Y., Fujita, Y., Ishima, T., Horio, M., Muneoka, K. T., Iyo, M., & Hashimoto, K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.008 · Cited by 99 · cited 1×
“Interestingly, minocycline also produces antidepressant-like effects in rats subjected to learned helplessness, a model of depression [39].”
BackgroundWang, K.-C., Fan, L.-W., Kaizaki, A., Pang, Y., Cai, Z., & Tien, L.-T. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.049 · Cited by 92
Liu, J., Gong, N., Huang, X., Reynolds, A. D., Mosley, R. L., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803330 · Cited by 89
Elevated expression of MCP-1, IL-2 and PTPR-N in basal ganglia of Tourette syndrome cases
Morer, Á., Chae, W., Henegariu, O., Bothwell, A. L. M., Leckman, J. F., & Kawiková, I. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.02.007 · Cited by 86 · cited 1×
“A nonsignificant two-fold increase in the expression of the surface marker CD45, which is higher in activated than resting microglia, was reported in postmortem basal ganglia [110].”
BackgroundZheng, L. T., Hwang, J., Ock, J., Lee, M. G., Lee, W., & Suk, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05675.x · Cited by 83 · cited 2×
“[77] L.”
BackgroundFénelon, G., Goujon, C., Gurruchaga, J.-M., Cesaro, P., Jarraya, B., Palfi, S., & Lefaucheur, J.-P. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.07.015 · Cited by 82
β 2-Adrenergic Receptor Activation and Genetic Polymorphisms in Autism: Data from Dizygotic Twins
Connors, S. L., Crowell, D. E., Eberhart, C. G., Copeland, J., Newschaffer, C. J., Spence, S. J., & Zimmerman, A. W. (2005) · Journal of Child Neurology · doi:10.1177/08830738050200110401 · Cited by 82
Zerrate, M. C., Pletnikov, M. V., Connors, S. L., Vargas, D. L., Seidler, F. J., Zimmerman, A. W., Slotkin, T. A., & Pardo, C. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121483 · Cited by 82
Ratnayake, U., Quinn, T. A., Castillo-Melendez, M., Dickinson, H., & Walker, D. W. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.08.011 · Cited by 75 · cited 1×
“An increased number of microglial cells and reduced arborization, which suggests activation, were also found in the hippocampus and the striatum of young rodents following embryonic polyriboinosinicpolyribocytidylic acid (Poly I:C) exposure [68, 69], which is proposed to recapitulate disrupted brain-immune interaction…”
BackgroundHou, Y., Wu, C. F., Yang, J., He, X., Bi, X. L., Yu, L., & Guo, T. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.05.006 · Cited by 72 · cited 2×
“[73] Y.”
BackgroundKnoepfler, P. S., Sykes, D. B., Pasillas, M. P., & Kamps, M. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204710 · Cited by 71
Avidan, H., Kipnis, J., Butovsky, O., Caspi, R. R., & Schwartz, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200424883 · Cited by 68
Increased microglial activation in the rat brain following neonatal exposure to a bacterial mimetic
Sominsky, L., Walker, A. K., Ong, L. K., Tynan, R. J., Walker, F. R., & Hodgson, D. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.038 · Cited by 67 · cited 1×
“Neonatal exposure of rats to LPS produces significantly increased anxiety-like behavior and hippocampal microglial activation in adulthood [42, 43].”
BackgroundLoss of Hoxb8 alters spinal dorsal laminae and sensory responses in mice
Holstege, J. C., de Graaff, W., Hossaini, M., Cano, S. C., Jaarsma, D., van den Akker, E., & Deschamps, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802176105 · Cited by 67 · cited 1×
“In the nervous system,Hoxb8plays an important role in the formation of the spinal cord, sensory responses, and development of noradrenergic autonomic neurons [105, 106].”
BackgroundKato, T. A., Monji, A., Yasukawa, K., Mizoguchi, Y., Horikawa, H., Seki, Y., Hashioka, S., Han, Y.-H., Kasai, M., Sonoda, N., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.019 · Cited by 66
Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics.
Wierzba‐Bobrowicz, T., Lewandowska, E., Kosno-Kruszewska, E., Lechowicz, W., Pasennik, E., & Schmidt-Sidor, B. (2004) · PubMed · Cited by 65
Liaury, K., Miyaoka, T., Tsumori, T., Furuya, M., Wake, R., Ieda, M., Tsuchie, K., Taki, M., Ishihara, K., Tanra, A. J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-56 · Cited by 57 · cited 1×
“Similar microglial abnormalities were observed in an experimental model of schizophrenia associated with hyperbilirubinemia [70].”
ResultWood, L., & Shepherd, G. M. G. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.01.018 · Cited by 54
Brain metabolism in rett syndrome: Age, clinical, and genotype correlations
Horská, A., Farage, L., Bibat, G., Nagae, L. M., Kaufmann, W. E., Barker, P. B., & Naidu, S. (2009) · Annals of Neurology · doi:10.1002/ana.21562 · Cited by 51 · cited 1×
“Interestingly, increased levels of glutamate and glutamine, measured using magnetic resonance spectroscopy (MRS), have been reported in young patients with Rett syndrome [96], suggesting that a similar glutamate dysregulation may occur in vivo in patients.”
BackgroundKipnis, J., & Schwartz, M. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:3:197 · Cited by 48
Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms
Kelly, D. L., Vyas, G. R., Richardson, C. M., Koola, M. M., McMahon, R. P., Buchanan, R. W., & Wehring, H. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.08.005 · Cited by 44 · cited 1×
“A few years ago, uncontrolled case series began to appear reporting therapeutic benefit from the addition of minocycline to antipsychotic treatment in schizophrenia [78, 79].”
BackgroundRosas, M., Osorio, F., Robinson, M. J., Davies, L. C., Dierkes, N., Jones, S. A., Reis e Sousa, C., & Taylor, P. R. (2011) · European Journal of Immunology · doi:10.1002/eji.201040962 · Cited by 42
Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion
Sargin, D., Hassouna, I., Sperling, S., Sirén, A., & Ehrenreich, H. (2009) · Glia · doi:10.1002/glia.20797 · Cited by 35 · cited 1×
“An animal model based on a cryolesion in the parietal cortex of juvenile mice, which produces later cortical atrophy and cognitive decline reminiscent of that observed in schizophrenia, induces a lasting increase in the number of microglia in cingulate cortex and hippocampus, with accompanying neurodegeneration [67].”
MethodChung, H., Kim, H., & Bae, H. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0833-y · Cited by 29
HoxB8 in noradrenergic specification and differentiation of the autonomic nervous system
Huber, L., Ferdin, M., Holzmann, J., Stubbusch, J., & Rohrer, H. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.12.026 · Cited by 25
STREPTOCOCCAL INFECTION, TOURETTE SYNDROME, AND OCD: IS THERE A CONNECTION? PANDAS: HORSE OR ZEBRA?
Swedo, S. E. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d8a638 · Cited by 25
Functional neuroimaging of minocycline's effect in a patient with schizophrenia
Chaves, C., de Marque, C. R., Wichert‐Ana, L., Maia‐de‐Oliveira, J. P., Itikawa, E. N., Crippa, J. A. S., Zuardi, A. W., Todd, K. G., Baker, G. B., Dursun, S. M., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.020 · Cited by 24 · cited 1×
“In one subject treated with eight weeks of minocycline, added to stable antipsychotic treatment, perfusion of the posterior cingulate cortex was reduced after the minocycline augmentation [80].”
BackgroundLentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia
Maiorino, C., Khorooshi, R., Ruffini, F., Løbner, M., Bergami, A., Garzetti, L., Martino, G., Owens, T., & Furlan, R. (2012) · Gene Therapy · doi:10.1038/gt.2012.58 · Cited by 22
Microglia activation in recent onset schizophrenia: A quantitative (R)-[11C]PK11195 study
van Berckel, B. N. M., Bossong, M. G., Boellaard, R., Kloet, R. W., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A. D., Cahn, W., Lammertsma, A. A., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.087 · Cited by 5
Liaury, K., Miyaoka, T., Tsumori, T., Wake, R., Furuya, M., Ieda, M., Tsuchie, K., Taki, M., Ishihara, K., & Horiguchi, J. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.07.1726 · Cited by 1
Research works printed but not linked: 9
- 2013, PLOS ONE, 8
- 2012, Handbook of Experimental Pharmacology, 267
- 2009, Frontiers in Behavioral Neuroscience, 3, 14
- 2011, Pharmacology Biochemistry and Behavior, 100, 601
- 2004, Folia Neuropathologica, 42, 157
- 2005, Folia Neuropathologica, 43, 81
- 2011, Schizophrenia Research, 131, 96
- 2011, Schizophrenia Research, 133, 257
- 2011, PLoS ONE, 6
Cited by
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
An environment-dependent transcriptional network specifies human microglia identity
Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., Jaeger, B. N., O’Connor, C., Fitzpatrick, C., Pasillas, M. P., et al. (2017) · Science · doi:10.1126/science.aal3222 · Cited by 1,220
“In addition, microglia may play roles in neurodevelopmental and psychiatric diseases such as autism, schizophrenia (Scz), and depression (16, 17).”
BackgroundDepression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944
“However, the specific role of microglia in major depression is only beginning to be explicated [4–7] and will be the topic of the current review.”
BackgroundCalcia, M. A., Bonsall, D. R., Bloomfield, P. S., Selvaraj, S., Barichello, T., & Howes, O. D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4218-9 · Cited by 709
“Of these, Iba-1 has been widely used to study microglia as its expression is specific and is expressed by both reactive and quiescent microglial cells (Frick et al. 2013).”
BackgroundInfluentialCannon, T. D., Chung, Y., He, G., Sun, D., Jacobson, A., van Erp, T. G. M., McEwen, S., Addington, J., Bearden, C. E., Cadenhead, K., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.023 · Cited by 599
“Although neuroinflammatory processes initiated during prenatal stress exposures could play a role (21), activation of such processes in association with the synaptic pruning characteristic of adolescent brain development represents an influence more proximal to psychosis onset (12, 17, 20, 21).”
Background
Metadata
- Authors
- Frick, L. R., Williams, K., & Pittenger, C.
- Affiliations
- Yale University (US)
- Corresponding author
- Pittenger, Christopher
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-10
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3652125
- OpenAlex
- W2157400052
- Cited by
- 299
- References
- 115
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 15 · 2023: 24 · 2022: 25 · 2021: 31 · 2020: 23 · 2019: 21 · 2018: 27 · 2017: 27 · 2016: 27 · 2015: 22 · 2014: 19 · 2013: 8
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Mental Health (R25MH077823)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- microglia, neuropsychiatric disorders, major depressive disorder, schizophrenia, autism spectrum disorder, obsessive-compulsive disorder, Tourette syndrome, synaptic pruning, adult neurogenesis, neuroinflammation, therapeutic target
- MeSH terms
- Animals, Autistic Disorder, Autopsy, Brain, Major Depressive Disorder, Tourette Syndrome, Humans, Inflammation, Obsessive-Compulsive Disorder, Schizophrenia, Microglia, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
